Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Treatment of Patients With Non-insulin-dependent Diabetes With the Implantable Insulin Pump

Treatment of Patients With Non-insulin-dependent Diabetes With the Implantable Insulin Pump To the Editor. —Dr Saudek and colleagues1 begin their article on intensive insulin therapy in individuals with NIDDM with the following sentence: "Intensified insulin therapy can be beneficial in preventing end-organ complications of diabetes, but imposes serious adverse effects of treatment" and conclude with "it is feasible to achieve very good glycemic control in NIDDM using either multiple-dose insulin or implantable insulin pump" therapy. These statements imply that it has been shown that strict glycemic control using frequent doses of insulin reduces the incidence of complications in NIDDM. However, that conclusion is based on results from the DCCT,2 which was performed exclusively in patients with IDDM.2 The suggestion that the results of the DCCT may be applicable to NIDDM patients is based on similarities in underlying mechanisms of complications occurring in patients with IDDM and those with NIDDM.3 Similar complications in different diseases may be treated using the same http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Treatment of Patients With Non-insulin-dependent Diabetes With the Implantable Insulin Pump

JAMA , Volume 277 (7) – Feb 19, 1997

Loading next page...
 
/lp/american-medical-association/treatment-of-patients-with-non-insulin-dependent-diabetes-with-the-m52JL8cRd0

References (6)

Publisher
American Medical Association
Copyright
Copyright © 1997 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1997.03540310027019
Publisher site
See Article on Publisher Site

Abstract

To the Editor. —Dr Saudek and colleagues1 begin their article on intensive insulin therapy in individuals with NIDDM with the following sentence: "Intensified insulin therapy can be beneficial in preventing end-organ complications of diabetes, but imposes serious adverse effects of treatment" and conclude with "it is feasible to achieve very good glycemic control in NIDDM using either multiple-dose insulin or implantable insulin pump" therapy. These statements imply that it has been shown that strict glycemic control using frequent doses of insulin reduces the incidence of complications in NIDDM. However, that conclusion is based on results from the DCCT,2 which was performed exclusively in patients with IDDM.2 The suggestion that the results of the DCCT may be applicable to NIDDM patients is based on similarities in underlying mechanisms of complications occurring in patients with IDDM and those with NIDDM.3 Similar complications in different diseases may be treated using the same

Journal

JAMAAmerican Medical Association

Published: Feb 19, 1997

There are no references for this article.